Interstitial Flow as a Guide for Lymphangiogenesis
暂无分享,去创建一个
[1] D. Vittet,et al. In Vitro Models of Vasculogenesis and Angiogenesis , 2001, Laboratory Investigation.
[2] A. D. Van den Abbeele,et al. Return of lymphatic function after flap transfer for acute lymphedema. , 1999, Annals of surgery.
[3] R. Jain,et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. , 1997, Science.
[4] W. Wood,et al. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[5] K. Alitalo,et al. VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissues , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] Y. Tan. Basic fibroblast growth factor-mediated lymphangiogenesis of lymphatic endothelial cells isolated from dog thoracic ducts: effects of heparin. , 1998, The Japanese journal of physiology.
[7] Z. Werb,et al. Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes , 1999, The Journal of Neuroscience.
[8] R K Jain,et al. Transport in lymphatic capillaries. I. Macroscopic measurements using residence time distribution theory. , 1996, The American journal of physiology.
[9] R. Kauppinen,et al. A model for gene therapy of human hereditary lymphedema , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. Stefanini,et al. Fixation of Ejaculated Spermatozoa for Electron Microscopy , 1967, Nature.
[11] D. Jackson,et al. LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.
[12] M. Swartz,et al. The physiology of the lymphatic system. , 2001, Advanced drug delivery reviews.
[13] G. Fields,et al. Matrix metalloproteinases and collagen catabolism. , 2002, Biopolymers.
[14] K. Alitalo,et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. , 1999, American Journal of Pathology.
[15] K. Alitalo,et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. , 1996, The EMBO journal.
[16] K. Alitalo,et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[17] G. Oliver,et al. Prox1 Function Is Required for the Development of the Murine Lymphatic System , 1999, Cell.
[18] J. M. Yoffey. The regeneration of lymphatics. , 1953, Journal international de chirurgie.
[19] K. Alitalo,et al. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. , 2000, The American journal of pathology.
[20] D. Ferguson,et al. Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic Endothelium* , 2001, The Journal of Biological Chemistry.
[21] R K Jain,et al. Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation. , 1999, Journal of biomechanics.
[22] E Bell,et al. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. Alitalo,et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. O. Poyton,et al. Oxygen sensing and molecular adaptation to hypoxia. , 1996, Physiological reviews.
[25] D. Ruiter,et al. Phenotype of Normal Cutaneous Microvasculature , 1996 .
[26] Seppo Ylä-Herttuala,et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 , 2001, Nature Medicine.
[27] K. Alitalo,et al. A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases. , 1996, The EMBO journal.
[28] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[29] S. Bellman,et al. Regeneration of surgically divided lymph vessels; an experimental study on the rabbit's ear. , 1959, Acta chirurgica Scandinavica.
[30] J. Cyster,et al. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Jain,et al. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. , 2001, Cancer research.
[32] D. Jackson. The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. , 2003, Trends in cardiovascular medicine.
[33] E. R. Clark,et al. Observations on the new growth of lymphatic vessels as seen in transparent chambers introduced into the rabbit's ear , 1932 .